Loading…
Innova Captab (INNOVACAP)₹1,069+0.15%Pharmaceuticals
In the Jun 2026 quarter (consolidated), Innova Captab reported sales of ₹470 Cr, up 33.8% from Jun 2025, and net profit of ₹44.01 Cr, up 42.0% year on year. For the year to Mar 2026, sales were ₹1,627 Cr and net profit ₹141 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 282 | 301 | 262 | 293 | 317 | 315 | 314 | 351 | 379 | 449 | 447 | 470 |
| Expenses | 242 | 258 | 225 | 252 | 268 | 270 | 267 | 299 | 329 | 381 | 383 | 397 |
| Operating Profit | 40.04 | 45.02 | 38.02 | 42.02 | 50.02 | 47.01 | 48.01 | 52.08 | 52.05 | 69.01 | 65.07 | 73.10 |
| OPM % | 14.1% | 15.0% | 14.0% | 14.0% | 16.0% | 15.0% | 15.0% | 15.0% | 14.0% | 15.0% | 15.0% | 16.0% |
| Other Income | 3.01 | 2.01 | 6.01 | 2.01 | 2.01 | 4.01 | 3.01 | 4.01 | 4.01 | 2.01 | 2.01 | 2.01 |
| Interest | 9.01 | 7.01 | 1.01 | 0.00 | 0.00 | 0.00 | 2.01 | 3.01 | 6.01 | 4.01 | 5.01 | 4.01 |
| Depreciation | 5.01 | 5.02 | 3.01 | 5.02 | 5.01 | 5.02 | 10.04 | 11.03 | 11.04 | 11.04 | 11.02 | 12.03 |
| Profit before tax | 29.97 | 34.97 | 39.95 | 38.96 | 46.95 | 45.93 | 38.99 | 42.98 | 38.95 | 55.92 | 50.97 | 58.98 |
| Tax % | 24.1% | 29.1% | 27.1% | 25.1% | 25.0% | 25.1% | 25.1% | 27.0% | 24.1% | 24.1% | 25.1% | 25.1% |
| Net Profit | 23.01 | 24.99 | 28.96 | 28.98 | 34.96 | 33.97 | 29.97 | 30.99 | 29.96 | 41.99 | 37.97 | 44.01 |
| EPS (Rs) | 4.75 | 4.38 | 5.01 | 5.13 | 6.10 | 5.96 | 5.16 | 5.40 | 5.16 | 7.35 | 6.63 | 7.68 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 355 | 372 | 410 | 799 | 923 | 1,078 | 1,240 | 1,627 | 1,744 |
| Expenses | 315 | 322 | 356 | 703 | 813 | 926 | 1,056 | 1,386 | 1,490 |
| Operating Profit | 41.07 | 51.08 | 54.03 | 96.10 | 114 | 154 | 186 | 243 | 259 |
| OPM % | 11.1% | 14.0% | 13.0% | 12.0% | 12.0% | 14.0% | 15.0% | 15.0% | 14.9% |
| Other Income | 0.00 | 1.01 | 1.01 | 3.01 | 9.01 | 12.02 | 12.02 | 7.01 | 10.04 |
| Interest | 6.01 | 5.01 | 4.01 | 6.01 | 20.04 | 21.04 | 2.01 | 17.03 | 19.04 |
| Depreciation | 11.03 | 10.03 | 6.02 | 8.03 | 11.04 | 16.04 | 25.09 | 45.10 | 45.13 |
| Profit before tax | 24.96 | 37.94 | 45.93 | 85.96 | 91.95 | 130 | 171 | 188 | 205 |
| Tax % | 20.0% | 26.1% | 26.1% | 25.1% | 26.1% | 27.1% | 25.1% | 25.1% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 0.00 | 0.00 | 0.99 | — |
| Net Profit | 19.99 | 27.99 | 33.98 | 63.97 | 67.93 | 93.88 | 128 | 141 | 154 |
| EPS (Rs) | 165.01 | 231.78 | 286.50 | 531.19 | 14.10 | 16.44 | 22.35 | 24.56 | 26.82 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 8.0% | — |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.01 | 12.03 | 12.02 | 12.02 | 48.11 | 57.05 | 57.08 | 57.14 |
| Reserves | 69.85 | 97.69 | 133 | 197 | 228 | 772 | 900 | 1,032 |
| Borrowings | 71.99 | 54.01 | 45.96 | 199 | 237 | 245 | 338 | 344 |
| Other Liabilities | 67.77 | 81.10 | 179 | 167 | 191 | 240 | 270 | 400 |
| Total Liabilities | 223 | 245 | 370 | 574 | 703 | 1,314 | 1,565 | 1,833 |
| Fixed Assets | 77.75 | 72.82 | 78.80 | 183 | 182 | 357 | 828 | 840 |
| CWIP | 0.00 | 0.00 | 6.99 | 0.00 | 21.98 | 341 | 23.01 | 15.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.92 |
| Other Assets | 144 | 172 | 283 | 392 | 500 | 616 | 716 | 937 |
| Inventories | 38.95 | 64.95 | 90.87 | 128 | 117 | 144 | 208 | 283 |
| Trade receivables | 90.97 | 86.97 | 139 | 213 | 265 | 288 | 332 | 437 |
| Cash & equivalents | 2.01 | 5.02 | 12.03 | 2.01 | 19.05 | 87.34 | 68.16 | 4.01 |
| Total Assets | 223 | 245 | 370 | 574 | 703 | 1,314 | 1,565 | 1,833 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 19.03 | 31.04 | 42.06 | 59.16 | 67.12 | 146 | 64.13 | 117 |
| Cash from investing activity | −9.02 | −6.01 | −20.04 | −188 | −91.20 | −500 | −152 | −107 |
| Cash from financing activity | −9.01 | −22.99 | −19.02 | 125 | 27.01 | 361 | 92.02 | −22.03 |
| Net cash flow | 1.01 | 1.01 | 3.01 | −5.01 | 3.01 | 8.02 | 4.01 | −12.03 |
| Capex | 8.04 | 4.01 | 19.06 | 80.37 | 79.27 | 288 | 173 | 68.23 |
| Free cash flow | 11.03 | 27.05 | 23.05 | −21.04 | −11.02 | −141 | −108 | 55.11 |
| CFO / OP % | 67.9% | 78.9% | 101.0% | 82.9% | 75.9% | 113.0% | 46.9% | 58.9% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 92 | 84 | 122 | 96 | 103 | 96 | 96 | 97 |
| Inventory days | 50 | 84 | 107 | 76 | 77 | 91 | 119 | 125 |
| Days payable | 80 | 92 | 132 | 86 | 105 | 113 | 115 | 141 |
| Cash conversion cycle | 64 | 77 | 99 | 87 | 77 | 75 | 101 | 82 |
| Working capital days | 30 | 45 | 39 | 37 | 58 | 77 | 81 | 86 |
| ROCE % | — | 25.9% | 28.0% | 30.9% | 23.9% | 18.9% | 14.9% | 15.0% |
For the Jun 2026 quarter, Innova Captab reported sales of ₹470 Cr, up 33.8% year on year and net profit of ₹44.01 Cr, up 42.0% year on year. The operating margin was 16.0%.
Innova Captab's sales for the year to Mar 2026 were ₹1,627 Cr; over the last twelve months they were ₹1,744 Cr.
Net profit for the year to Mar 2026 was ₹141 Cr, and ₹154 Cr over the last twelve months. Earnings per share over the same trailing period were ₹26.82.
Innova Captab reported borrowings of ₹344 Cr at Mar 2026, against cash and equivalents of ₹4.01 Cr.
Cash from operations was ₹117 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹55.11 Cr.